(Q35678470)

9 August 2017

1 reference

title

Current concepts in SARS treatment (English)

1 reference

9 August 2017

0 references

Takeshi Fujii

1

1 reference

PubMed ID

14991510

9 August 2017

Tetsuya Nakamura

series ordinal

2

1 reference

PubMed ID

14991510

9 August 2017

Aikichi Iwamoto

series ordinal

3

1 reference

9 August 2017

1 February 2004

1 reference

Journal of Infection and Chemotherapy

9 August 2017

1 reference

9 August 2017

10

1 reference

9 August 2017

1

1 reference

9 August 2017

1-7

1 reference

https://scigraph.springernature.com/pub.10.1007/s10156-003-0296-9

9 August 2017

0 references

cites work

Hepatitis C virus infection

1 reference

12 December 2020

A retrospective study of 78 patients with severe acute respiratory syndrome.

1 reference

12 December 2020

Fatal aspergillosis in a patient with SARS who was treated with corticosteroids

1 reference

12 December 2020

ICU management of severe acute respiratory syndrome

1 reference

12 December 2020

Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus

1 reference

12 December 2020

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

1 reference

12 December 2020

The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses

1 reference

12 December 2020

Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome.

1 reference

12 December 2020

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

1 reference

12 December 2020

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Respiratory syncytial virus (RSV) disease and prospects for its control

1 reference

12 December 2020

A cluster of cases of severe acute respiratory syndrome in Hong Kong.

1 reference

12 December 2020

Varicella pneumonia in patients with HIV/AIDS.

1 reference

12 December 2020

Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial

1 reference

12 December 2020

Treatment of SARS with human interferons.

1 reference

12 December 2020

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

1 reference

12 December 2020

A major outbreak of severe acute respiratory syndrome in Hong Kong

1 reference

12 December 2020

Severe Acute Respiratory Syndrome: Clinical Outcome and Prognostic Correlates

1 reference

12 December 2020

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

1 reference

12 December 2020

Effect of ribavirin on viral hepatitis in laboratory animals

1 reference

12 December 2020

Treatment of SARS with human interferons

1 reference

12 December 2020

Identification of severe acute respiratory syndrome in Canada

1 reference

12 December 2020

Treatment of SARS with human interferons.

1 reference

12 December 2020

Critics slam treatment for SARS as ineffective and perhaps dangerous

1 reference

12 December 2020

Antiviral activity of interferon against transmissible gastroenteritis virus in cell culture and ligated intestinal segments in neonatal pigs

1 reference

12 December 2020

Familial cases of severe measles pneumonia.

1 reference

12 December 2020

Immunomodulation by macrolide antibiotics

1 reference

12 December 2020

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

12 December 2020

Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China

1 reference

12 December 2020

Critically ill patients with severe acute respiratory syndrome.

1 reference

12 December 2020

Immunomodulatory effects of quinolones

1 reference

12 December 2020

Aetiology: Koch's postulates fulfilled for SARS virus

1 reference

12 December 2020

Lowered yields of virus-induced interferon production in leukocyte cultures and risk of recurrent respiratory infections in children

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS): epidemiology, diagnosis and management

1 reference

12 December 2020

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)

1 reference

12 December 2020

WHO issues consensus document on the epidemiology of SARS

1 reference

12 December 2020

Antiviral treatment of SARS: can we draw any conclusions?

1 reference

12 December 2020

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

12 December 2020

Lung pathology of fatal severe acute respiratory syndrome.

1 reference

12 December 2020

Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts

1 reference

12 December 2020

Corticosteroid therapy in severe illness

1 reference

12 December 2020

A hospital outbreak of severe acute respiratory syndrome in Guangzhou, China

1 reference

12 December 2020

Development of a standard treatment protocol for severe acute respiratory syndrome

1 reference

12 December 2020

Management of severe acute respiratory syndrome: the Hong Kong University experience.

1 reference

12 December 2020

Ribavirin in the treatment of SARS: A new trick for an old drug?

1 reference

12 December 2020

Coronavirus as a possible cause of severe acute respiratory syndrome

1 reference

12 December 2020

Early diagnosis of SARS coronavirus infection by real time RT-PCR.

1 reference

12 December 2020

Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.

1 reference

12 December 2020

Lassa fever. Effective therapy with ribavirin

1 reference

12 December 2020

10.1007/S10156-003-0296-9

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14991510